Collegeville, PA, United States of America

Lance Howard Ridgers

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Work of Lance Howard Ridgers

Introduction: Lance Howard Ridgers, an accomplished inventor based in Collegeville, PA, has made significant contributions to the field of medicinal chemistry. With two patents to his name, Ridgers has focused on developing compounds that have the potential to revolutionize treatments for various diseases, particularly cancer and autoimmune disorders.

Latest Patents: Ridgers' latest patents include groundbreaking inventions in the field of fatty acid synthase inhibitors and quinoline derivatives. The first patent relates to spirocyclic piperidines designed for the modulation and inhibition of fatty acid synthase (FAS), presenting promising applications in cancer treatment. The second patent introduces a method for inhibiting the activity of PI3 kinases using quinoline derivatives. This invention outlines treatment methods for a range of disease states, including autoimmune disorders, inflammatory diseases, and certain types of cancer.

Career Highlights: Throughout his career, Lance Howard Ridgers has been associated with notable organizations, including GlaxoSmithKline LLC and GlaxoSmithKline Intellectual Property Limited. His work in these companies has helped pave the way for advanced medical therapies, reflecting his commitment to advancing healthcare through innovative inventions.

Collaborations: Ridgers has collaborated with esteemed colleagues such as Nicholas D. Adams and Joelle Lorraine Burgess. These collaborations have played a crucial role in refining his inventions and enhancing the effectiveness of the developed therapies.

Conclusion: Lance Howard Ridgers stands out as an innovative inventor dedicated to improving health outcomes through his patents. His dual focus on fatty acid synthase inhibitors and quinoline derivatives reflects a deep understanding of medicinal chemistry and a commitment to addressing critical health challenges. As he continues to explore new avenues in medicinal inventions, Ridgers remains a valuable contributor to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…